Skip to main content
Home/Blog/Healthcare PE

Best AI OS for Portfolio EBITDA Expansion

Written by - Samara Strategy TeamLast Updated - September 11, 2026

Portfolio-wide EBITDA growth is the sum of small revenue leaks fixed at every location, not one big lever pulled at headquarters. Here's where those leaks are and how an AI OS closes them at scale.

Follow Samara on Google

Set Samara as a preferred source and our research shows up more often in your Google Search results, Top Stories, and AI Overviews.

Make Samara a preferred source

Key Insight

Portfolios that standardize on one AI OS typically recover 6-10% in previously lost appointment revenue across all locations within the first two quarters, compounding into meaningful EBITDA dollars at the portfolio level.

Portfolio EBITDA Is a Sum, Not a Single Number

Unlike platform EBITDA, which lives at the corporate layer, portfolio EBITDA is the aggregate of everything happening — or not happening — at every individual location. A no-show at one clinic is a small number. The same no-show rate repeated across 40 locations, every week, for a year, is a material line item that rarely gets attributed correctly because it never shows up as one visible loss.

This is why portfolio EBITDA expansion looks less like a strategic pivot and more like plumbing: finding where revenue leaks out at the location level and closing those leaks consistently everywhere, not just at the best-run sites.

Where the Leaks Actually Are

No-shows and late cancellations with no backfill. An empty slot that could have been filled from a waitlist is lost revenue that never appears on any single report as a loss.

Inconsistent recall and follow-up. Patients due for a follow-up who never get contacted represent both lost revenue and a lost patient, and the gap is invisible until churn shows up months later.

Uneven performance across sites. A handful of well-run locations often mask a larger number of underperforming ones in a blended portfolio average.

What to Look for in an AI OS

Automated backfill from a live waitlist. Every cancellation should trigger an immediate attempt to fill the slot, not a note for staff to follow up on later.

Recall and follow-up that runs without depending on staff bandwidth. The system should track who's due for a return visit and reach out automatically, at every location, regardless of that site's staffing that week.

Site-by-site visibility that surfaces the real spread. Leadership needs to see which specific locations are leaking revenue, not just a blended portfolio number that hides it.

Metric Manual, location-by-location One AI OS across the portfolio
Cancellation backfill rate Under 30% 70%+
Recall/follow-up consistency Staffing-dependent Uniform across all sites
Portfolio revenue visibility Blended monthly average Live, site-by-site

Frequently Asked Questions

How much EBITDA is typically recoverable from fixing these leaks across a portfolio?

Most portfolios recover 6-10% in previously lost appointment revenue within the first two quarters, driven primarily by cancellation backfill and recall consistency — figures that vary by starting no-show rate and portfolio size.

Do underperforming sites need to be fixed individually first?

No. Deploying one AI OS portfolio-wide brings every site, including the weakest performers, onto the same automated process simultaneously rather than requiring a site-by-site turnaround plan.

How is this different from a revenue cycle management initiative?

RCM addresses billing and collections after a visit happens. This addresses whether the visit happens at all — filling the slot, keeping the follow-up on schedule, and preventing the revenue loss before it's ever billed.

Healthcare PEHealthcare AIWorkflow Automation

Ready to transform your practice operations?

Join 500+ healthcare leaders deploying specialized AI workforces to drive EBITDA growth.

See a live demo of the Samara AI platform in under 15 minutes.

Samara Assistant

Ask me anything

Welcome to Samara

Tell us who you are to get started